Integer Holdings Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.2Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
35clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $445K
2020 $450K
2021 $300K
2022 $447K
2023 $449K
2024 $54K
2025 $31K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Cardiovascular Disease $1.1M
Interventional Cardiology $505K
Urology $304K
Orthopaedic Surgery $91K
Diagnostic Radiology $51K
Pediatric Cardiology $39K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Robert Vantassel Minneapolis, MN Cardiovascular Disease $492,641.66
Robert Schwartz Minneapolis, MN Cardiovascular Disease $492,641.65
Wesley Pedersen Minneapolis, MN Interventional Cardiology $492,641.65
Stephen Dretler Boston, MA Urology $298,149.17
Douglas Roger Palm Springs, CA Orthopaedic Surgery $90,599.70
Joseph Mcbride Omaha, NE Diagnostic Radiology $43,187.50
Jay Simonson St Louis Park, MN Cardiovascular Disease $40,050.00
Christopher Curzon San Antonio, TX Pediatric Cardiology $39,219.95
Hosakote Nagaraj Alabaster, AL Cardiovascular Disease $30,354.58
Kim Duncan Omaha, NE Thoracic Surgery (Cardiothoracic Vascular Surgery) $21,850.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.